Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–70
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
histologically verified diagnosis of breast carcinoma, at first diagnosis
restricted previous adjuvant chemotherapy (completed \>6 months prior the study)
measurable and/or non-measurable disease
previous radiotherapy is allowed if:terminated at least 10 days prior the sudy therapy, at least one target lesion for evaluation of tumor response has not been irradiated
performance status 0-2 (WHO, Zubrod)
adequate bone marrow reserve defined
adequate liver / renal functions defined
You may not be if
any prior systematic chemotherapy for metastatic breast cancer
expected survival time less than 12 weeks
past or current history of malignant neoplasm other than breast carcinoma
* except for cured non-melanoma skin cancer or curatively treated in situ carcinoma of the cervix uteri
known brain metastases/leptomeningeal involvement
active uncontrolled infection
symptomatic peripheral neuropathy \> grade 2 according to NCI
patients whose lesions are assessable only by radionuclide scan or patients with sclerotic bone lesions as the only site of disease
concomitant illness that is contraindication to the use of corticosteroids
other concomitant serious illness or medical condition, which may worsen due to the treatment
Clareo Health | Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer
